Douglas MacDonald

2.5k total citations · 1 hit paper
66 papers, 1.7k citations indexed

About

Douglas MacDonald is a scholar working on Epidemiology, Hepatology and Political Science and International Relations. According to data from OpenAlex, Douglas MacDonald has authored 66 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Hepatology and 7 papers in Political Science and International Relations. Recurrent topics in Douglas MacDonald's work include Liver Disease Diagnosis and Treatment (15 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (9 papers). Douglas MacDonald is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (9 papers). Douglas MacDonald collaborates with scholars based in United Kingdom, United States and Canada. Douglas MacDonald's co-authors include William Gelson, Kosh Agarwal, David Mutimer, William L. Irving, Graham R. Foster, John McLauchlan, Ben Hudson, Alex J Walker, Suman Verma and Ashley Brown and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Douglas MacDonald

58 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

2016 328 citations Graham R. Foster, William L. Irving et al. profile →

Peers

Countries citing papers authored by Douglas MacDonald

Since Specialization

Citations

This map shows the geographic impact of Douglas MacDonald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas MacDonald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas MacDonald more than expected).

Fields of papers citing papers by Douglas MacDonald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas MacDonald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas MacDonald. The network helps show where Douglas MacDonald may publish in the future.

Co-authorship network of co-authors of Douglas MacDonald

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas MacDonald. A scholar is included among the top collaborators of Douglas MacDonald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas MacDonald. Douglas MacDonald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Hepatocellular carcinoma surveillance: minimum standards	Frontline Gastroenterology	Rohini Sharma, Aloysious Aravinthan et al.	1
2	Demographic disparities in blood-borne-virus screening in two London Emergency Departments: a case for implied consent	AIDS Care	Cassandra Fairhead, Tristan Barber et al.	0
3	Clearance of Hepatitis C Virus following Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma: Case Report	Case Reports in Gastroenterology	Harry Wilson, Douglas MacDonald et al.	0
4	Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapy	Sexually Transmitted Infections	Sheila Lumley, Khadija Said Mohammed et al.	1
5	Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK	Liver International	Douglas MacDonald, Paul Richardson et al.	9
6	Opt-out testing for hepatitis B and C infections in adults attending the emergency department of a large London teaching hospital	Journal of Clinical Virology	Jingwei Zeng, Douglas MacDonald et al.	2
7	Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination	Journal of Viral Hepatitis	Colette Smith, Alison Rodger et al.	3
8	The fate of indeterminate liver lesions: What proportion are precursors of hepatocellular carcinoma?	BMC Gastroenterology	Sara Cococcia, Brian Hogan et al.	1
9	Competition Stress Leads to a Blunting of the Cortisol Awakening Response in Elite Rowers	Frontiers in Psychology	Douglas MacDonald, Mark Wetherell	17
10	Liver transplant listing for hepatitis C‐associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct‐acting antiviral therapy	Journal of Viral Hepatitis	Alexander Gimson, Kosh Agarwal et al.	18
11	Successful hepatitis C treatment in advanced cirrhosis with DAA reduces HCC incidence	UCL Discovery (University College London)	Andrea Affronti, J. A. Catt et al.	2
12	Harnessing alveolar macrophages for sustained mucosal T-cell recall confers long-term protection to mice against lethal influenza challenge without clinical disease	Mucosal Immunology	Douglas MacDonald, Harsimran Singh et al.	18
13	What does the Olympics mean to you	Psychologist	Jan Burns, Guy Claxton et al.	0
14	Understanding the Selection of Policy Instruments in Canadian Climate-Change Policy	SSRN Electronic Journal	Douglas MacDonald et al.	3
15	Kaposi's Sarcoma-Associated Herpesvirus vFLIP and Human T Cell Lymphotropic Virus Type 1 Tax Oncogenic Proteins Activate IκB Kinase Subunit γ by Different Mechanisms Independent of the Physiological Cytokine-Induced Pathways	Journal of Virology	Akira Shimizu, Mehdi Baratchian et al.	15
16	PD‐L1 co‐stimulation contributes to ligand‐induced T cell receptor down‐modulation on CD8 ⁺ T cells	EMBO Molecular Medicine	Katarzyna Karwacz, Christopher Bricogne et al.	207
17	Alberta Climate-Change Policy in the Canada-Us Context	SSRN Electronic Journal	Douglas MacDonald et al.	0
18	CD44 isoform expression on colonic epithelium mediates lamina propria lymphocyte adhesion and is controlled by Th1 and Th2 cytokines	European Journal of Gastroenterology & Hepatology	Douglas MacDonald, Shih‐Hsing Leir et al.	15
19	Comparison of ultrasound examination with bone scintiscan in the diagnosis of stress fractures.	PubMed	Douglas MacDonald et al.	16
20	Long-Lived Cobalt Isotopes Observed in Fallout	Science	Douglas MacDonald et al.	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact